Royal Bank Of Canada Helius Medical Technologies, Inc. Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.14 - $0.25 $0 - $1	-5 Reduced 2.2%	222 $0
Q1 2023 May 15, 2023	BUY	$0.23 - $0.41 $24 - $44	108 Added 90.76%	227 $0
Q4 2022 Feb 14, 2023	BUY	$0.22 - $14.5 $3 - $246	17 Added 16.67%	119 $0
Q1 2022 May 16, 2022	BUY	$3.07 - $5.55 $33 - $61	11 Added 12.09%	102 $0
Q3 2021 Nov 15, 2021	BUY	$12.9 - $16.83 $606 - $791	47 Added 106.82%	91 $1,000
Q2 2021 Aug 16, 2021	BUY	$13.28 - $18.45 $584 - $811	44 New	44 $1,000

Ticker HSDT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,197,200
Market Cap $12.7M
Description
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gai...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.